CCMI
WST icon

Creative Capital Management Investments’s West Pharmaceutical WST Stock Holding History

Creative Capital Management Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95K Buy
+11
New +$3.36K ﹤0.01% 498

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return

Creative Capital Management Investments's WST Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in West Pharmaceutical (WST) in Q2 2026: 11 shares worth $3.95K. The stake represents ﹤0.01% of the portfolio and ranks #498 among its holdings.

189 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Creative Capital Management Investments held 11 shares of West Pharmaceutical worth $3.95K as of Q2 2026.
  • West Pharmaceutical was a new Creative Capital Management Investments position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #498 holding.
  • 189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.